Gene and Protein Expression Patterns in Predicting Response to Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer

Clinical trial NCT00898742 · TERMINATED

Trial details

NCT number: NCT00898742
Sponsor: Vanderbilt-Ingram Cancer Center
Status: TERMINATED
Study type: OBSERVATIONAL

Head and Neck Cancer

Start date: 2007-04-01
Primary completion: 2010-06-01
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.